Form 8-K - Current report:
SEC Accession No. 0001213900-24-091422
Filing Date
2024-10-29
Accepted
2024-10-29 08:00:08
Documents
17
Period of Report
2024-10-24
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0218848-8k_180life.htm   iXBRL 8-K 50734
2 OFFER LETTER BETWEEN 180 LIFE SCIENCE CORP. AND JAY GOODMAN (DIRECTOR) DATED OCT ea021884801ex10-1_180life.htm EX-10.1 13876
3 180 LIFE SCIENCES CORP. PRESS RELEASE DATED OCTOBER 29, 2024 ea021884801ex99-1_180life.htm EX-99.1 14753
4 GRAPHIC ex10-1_001.jpg GRAPHIC 2937
  Complete submission text file 0001213900-24-091422.txt   318821

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE atnf-20241024.xsd EX-101.SCH 3787
6 XBRL DEFINITION FILE atnf-20241024_def.xml EX-101.DEF 26629
7 XBRL LABEL FILE atnf-20241024_lab.xml EX-101.LAB 36680
8 XBRL PRESENTATION FILE atnf-20241024_pre.xml EX-101.PRE 25253
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0218848-8k_180life_htm.xml XML 5816
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 241402724
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)